Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chul Kim

Showing results (31-40 of 5,179) with videos related to

Pageof 518
Sort By:
Mayo Clinic Proceedings|May 30, 2016
Strength of Validation for Surrogate End Points Used in the US Food and Drug Administration's Approval of Oncology DrugsChul Kim, Vinay Prasad
Archives of Pharmacal Research|June 25, 2005
Free radical scavenging and hepatoprotective constituents from the leaves of Juglans sinensisRen-Bo An, Hyun-Chul Kim, Yu-Hua Tian, et al.
JAMA Internal Medicine|October 27, 2015
Cancer Drugs Approved on the Basis of a Surrogate End Point and Subsequent Overall Survival: An Analysis of 5 Years of US Food and Drug Administration ApprovalsChul Kim, Vinay Prasad
Physical Review Letters|August 29, 2014
Factorization theorem for high-energy scattering near the end pointJunegone Chay, Chul Kim
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 28, 2020
Durable Response in Patients With Thymic Carcinoma Treated With Pembrolizumab After Prolonged Follow-UpGiuseppe Giaccone, Chul Kim
Annals of Translational Medicine|January 17, 2017
Lessons learned from BATTLE-2 in the war on cancer: the use of Bayesian method in clinical trial designChul Kim, Giuseppe Giaccone
Nature Reviews. Clinical Oncology|March 31, 2018
Precision oncology in non-small-cell lung cancer: opportunities and challengesChul Kim, Giuseppe Giaccone
Expert Opinion on Investigational Drugs|December 9, 2017
MEK inhibitors under development for treatment of non-small-cell lung cancerChul Kim, Giuseppe Giaccone
The Journal of Physical Chemistry. B|August 15, 2008
Pore structure, thinning effect, and lateral diffusive dynamics of oriented lipid membranes interacting with antimicrobial peptide protegrin-1: 31P and 2H solid-state NMR studySungsool Wi, Chul Kim
European Journal of Cancer (Oxford, England : 1990)|May 7, 2020
Immune checkpoint inhibitor use and tuberculosis: a systematic review of the literatureJacob Zaemes, Chul Kim
Pageof 518

Showing results (31-40 of 5,179) with videos related to

Sort By:
Pageof 518
Mayo Clinic Proceedings|May 30, 2016
Strength of Validation for Surrogate End Points Used in the US Food and Drug Administration's Approval of Oncology DrugsChul Kim, Vinay Prasad
Archives of Pharmacal Research|June 25, 2005
Free radical scavenging and hepatoprotective constituents from the leaves of Juglans sinensisRen-Bo An, Hyun-Chul Kim, Yu-Hua Tian, et al.
JAMA Internal Medicine|October 27, 2015
Cancer Drugs Approved on the Basis of a Surrogate End Point and Subsequent Overall Survival: An Analysis of 5 Years of US Food and Drug Administration ApprovalsChul Kim, Vinay Prasad
Physical Review Letters|August 29, 2014
Factorization theorem for high-energy scattering near the end pointJunegone Chay, Chul Kim
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 28, 2020
Durable Response in Patients With Thymic Carcinoma Treated With Pembrolizumab After Prolonged Follow-UpGiuseppe Giaccone, Chul Kim
Annals of Translational Medicine|January 17, 2017
Lessons learned from BATTLE-2 in the war on cancer: the use of Bayesian method in clinical trial designChul Kim, Giuseppe Giaccone
Nature Reviews. Clinical Oncology|March 31, 2018
Precision oncology in non-small-cell lung cancer: opportunities and challengesChul Kim, Giuseppe Giaccone
Expert Opinion on Investigational Drugs|December 9, 2017
MEK inhibitors under development for treatment of non-small-cell lung cancerChul Kim, Giuseppe Giaccone
The Journal of Physical Chemistry. B|August 15, 2008
Pore structure, thinning effect, and lateral diffusive dynamics of oriented lipid membranes interacting with antimicrobial peptide protegrin-1: 31P and 2H solid-state NMR studySungsool Wi, Chul Kim
European Journal of Cancer (Oxford, England : 1990)|May 7, 2020
Immune checkpoint inhibitor use and tuberculosis: a systematic review of the literatureJacob Zaemes, Chul Kim
Pageof 518